H I P ISSN 1120-7000
In this edition of HIP International I would like to highlight the benefits and limitations of registry studies. The value of registry data is unquestionable for the detection of underperforming implants and for mapping trends in arthroplasty practice. Registries offer vast quantities of prospectively collected data, which may be analysed in a retrospective fashion. When registry data is used in a manner which exceeds its original purpose, caution should be employed when interpreting the findings. The appropriate use of registry data in research should therefore be safeguarded, and the statistical complexity of working with 'big data' and correctly adjusting for confounders should not be underestimated.
The study from Henrik Malchau's group in this edition illustrates these points. Malchau and colleagues use Australian registry data to show an association between ceramic-on-ceramic bearings and a lower rate of revision for prosthetic joint infection (PJI). They hypothesise that the surface property of ceramic may reduce bacterial attachment. Of course, there may be many factors predisposing patients selected for ceramic-on-ceramic bearings to a lower risk of developing a PJI. Without controlling for all factors, known and unknown, residual confounding may explain for the observed association, despite the best efforts of the research team. Registries therefore demonstrate association, but not proof of causation. Should we therefore write off the findings of such studies?
I would argue not. Of course, the association between ceramics and lower rates of PJI needs first to be confirmed within other registries. One might also expect to observe an interim effect size within larger samples when ceramic-on-polyethylene is used. If the protective effect of ceramic is confirmed, biomaterial studies should confirm the mechanism of impaired surface attachment of bacteria to ceramics, and this in turn may potentially lead to novel antimicrobial surface treatments. The groups of patients at risk who would benefit most would also need to be identified. Using registry observations to generate a hypothesis, followed by rigorous testing via different study designs may yield important developments, and is worthy of discussion in this journal. After all, for rare adverse events like PJI, conducting appropriately powered randomised trials is currently too resource consuming.
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